<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">32856205</PMID><DateCompleted><Year>2021</Year><Month>10</Month><Day>04</Day></DateCompleted><DateRevised><Year>2021</Year><Month>12</Month><Day>04</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1559-1166</ISSN><JournalIssue CitedMedium="Internet"><Volume>71</Volume><Issue>3</Issue><PubDate><Year>2021</Year><Month>Mar</Month></PubDate></JournalIssue><Title>Journal of molecular neuroscience : MN</Title><ISOAbbreviation>J Mol Neurosci</ISOAbbreviation></Journal><ArticleTitle>ClC-2-like Chloride Current Alterations in a Cell Model of Spinal and Bulbar Muscular Atrophy, a Polyglutamine Disease.</ArticleTitle><Pagination><StartPage>662</StartPage><EndPage>674</EndPage><MedlinePgn>662-674</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1007/s12031-020-01687-5</ELocationID><Abstract><AbstractText>Spinal and bulbar muscular atrophy (SBMA) is a neuromuscular disease caused by expansions of a polyglutamine (polyQ) tract in the androgen receptor (AR) gene. SBMA is associated with the progressive loss of lower motor neurons, together with muscle weakness and atrophy. PolyQ-AR is converted to a toxic species upon binding to its natural ligands, testosterone, and dihydrotestosterone (DHT). Our previous patch-clamp studies on a motor neuron-derived cell model of SBMA showed alterations in voltage-gated ion currents. Here, we identified and characterized chloride currents most likely belonging to the chloride channel-2 (ClC-2) subfamily, which showed significantly increased amplitudes in the SBMA cells. The treatment with the pituitary adenylyl cyclase-activating polypeptide (PACAP), a neuropeptide with a proven protective effect in a mouse model of SBMA, recovered chloride channel current alterations in SBMA cells. These observations suggest that the CIC-2 currents are affected in SBMA, an alteration that may contribute and potentially determine the pathophysiology of the disease.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y" EqualContrib="Y"><LastName>Mart&#xed;nez-Rojas</LastName><ForeName>Vladimir A</ForeName><Initials>VA</Initials><AffiliationInfo><Affiliation>Institute of Biophysics (IBF), Trento Unit, National Research Council (CNR) &amp; LabSSAH, Bruno Kessler Foundation (FBK), Trento, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Jim&#xe9;nez-Gardu&#xf1;o</LastName><ForeName>Aura M</ForeName><Initials>AM</Initials><AffiliationInfo><Affiliation>Institute of Biophysics (IBF), Trento Unit, National Research Council (CNR) &amp; LabSSAH, Bruno Kessler Foundation (FBK), Trento, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Departamento de Ciencias de la Salud, Escuela de Ciencias, Universidad de las Am&#xe9;ricas Puebla (UDLAP), San Andr&#xe9;s Cholula, Puebla, Mexico.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Michelatti</LastName><ForeName>Daniela</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Institute of Biophysics (IBF), Trento Unit, National Research Council (CNR) &amp; LabSSAH, Bruno Kessler Foundation (FBK), Trento, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>CIBIO Department, Laboratory of Chromatin Biology and Epigenetics, University of Trento, Trento, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tosatto</LastName><ForeName>Laura</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Institute of Biophysics (IBF), Trento Unit, National Research Council (CNR) &amp; LabSSAH, Bruno Kessler Foundation (FBK), Trento, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Marchioretto</LastName><ForeName>Marta</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Institute of Biophysics (IBF), Trento Unit, National Research Council (CNR) &amp; LabSSAH, Bruno Kessler Foundation (FBK), Trento, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Arosio</LastName><ForeName>Daniele</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Institute of Biophysics (IBF), Trento Unit, National Research Council (CNR) &amp; LabSSAH, Bruno Kessler Foundation (FBK), Trento, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Basso</LastName><ForeName>Manuela</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>CIBIO Department, Laboratory of Transcriptional Neurobiology, University of Trento, Trento, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pennuto</LastName><ForeName>Maria</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Biomedical Sciences, University of Padova, Padova, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Padova Neuroscience Center (PNC), University of Padova, Padova, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Veneto Institute of Molecular Medicine, Padova, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Musio</LastName><ForeName>Carlo</ForeName><Initials>C</Initials><Identifier Source="ORCID">0000-0003-2106-9931</Identifier><AffiliationInfo><Affiliation>Institute of Biophysics (IBF), Trento Unit, National Research Council (CNR) &amp; LabSSAH, Bruno Kessler Foundation (FBK), Trento, Italy. carlo.musio@cnr.it.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>Bando Progetti Strategici di Ateneo</GrantID><Agency>Universit&#xe0; degli Studi di Trento</Agency><Country/></Grant><Grant><GrantID>TCP12013</GrantID><Agency>Fondazione Telethon</Agency><Country/></Grant><Grant><GrantID>479363</GrantID><Agency>Muscular Dystrophy Association</Agency><Country/></Grant><Grant><GrantID>22221</GrantID><Agency>Association Fran&#xe7;aise contre les Myopathies</Agency><Country/></Grant><Grant><GrantID>Great project "MaDEleNA"</GrantID><Agency>Provincia Autonoma di Trento (IT)</Agency><Country/></Grant><Grant><GrantID>Bando Post-Doc</GrantID><Agency>Fondazione Cassa Di Risparmio Di Trento E Rovereto</Agency><Country/></Grant><Grant><GrantID>Bando Post-doc</GrantID><Agency>Fondazione Cassa Di Risparmio Di Trento E Rovereto</Agency><Country/></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2020</Year><Month>08</Month><Day>28</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>J Mol Neurosci</MedlineTA><NlmUniqueID>9002991</NlmUniqueID><ISSNLinking>0895-8696</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000090007">CLC-2 Chloride Channels</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D018118">Chloride Channels</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C000715428">Clcn2 protein, mouse</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D051219">Pituitary Adenylate Cyclase-Activating Polypeptide</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000200" MajorTopicYN="N">Action Potentials</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D055534" MajorTopicYN="N">Bulbo-Spinal Atrophy, X-Linked</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000090007" MajorTopicYN="N">CLC-2 Chloride Channels</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002478" MajorTopicYN="N">Cells, Cultured</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018118" MajorTopicYN="N">Chloride Channels</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D051379" MajorTopicYN="N">Mice</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009474" MajorTopicYN="N">Neurons</DescriptorName><QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName><QualifierName UI="Q000502" MajorTopicYN="N">physiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D051219" MajorTopicYN="N">Pituitary Adenylate Cyclase-Activating Polypeptide</DescriptorName><QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Chloride currents</Keyword><Keyword MajorTopicYN="N">ClC-2 channels</Keyword><Keyword MajorTopicYN="N">PACAP</Keyword><Keyword MajorTopicYN="N">Patch-clamp</Keyword><Keyword MajorTopicYN="N">PolyQ-AR cells</Keyword><Keyword MajorTopicYN="N">Spinal and bulbar muscular atrophy (SBMA)</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2020</Year><Month>5</Month><Day>18</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2020</Year><Month>8</Month><Day>14</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2020</Year><Month>8</Month><Day>29</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>10</Month><Day>5</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2020</Year><Month>8</Month><Day>29</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">32856205</ArticleId><ArticleId IdType="doi">10.1007/s12031-020-01687-5</ArticleId><ArticleId IdType="pii">10.1007/s12031-020-01687-5</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Accardi A, Picollo A (2010) CLC channels and transporters: proteins with borderline personalities. Biochim Biophys Acta 1798:1457&#x2013;1464</Citation><ArticleIdList><ArticleId IdType="pubmed">20188062</ArticleId><ArticleId IdType="pmc">2885512</ArticleId></ArticleIdList></Reference><Reference><Citation>Akopian G, Barry J, Cepeda C, Levine MS (2016) Altered membrane properties and firing patterns of external globus pallidus neurons in the R6/2 mouse model of Huntington&#x2019;s disease. J Neurosci Res 94:1400&#x2013;1410</Citation><ArticleIdList><ArticleId IdType="pubmed">27618125</ArticleId><ArticleId IdType="pmc">5069159</ArticleId></ArticleIdList></Reference><Reference><Citation>Aromataris EC, Rychkov GY (2006) ClC-1 chloride channel: matching its properties to a role in skeletal muscle. Clin Exp Pharmacol Physiol 33:1118&#x2013;1123</Citation><ArticleIdList><ArticleId IdType="pubmed">17042925</ArticleId></ArticleIdList></Reference><Reference><Citation>Arosio D, Ratto GM (2014) Twenty years of fluorescence imaging of intracellular chloride. Front Cell Neurosci 8:258</Citation><ArticleIdList><ArticleId IdType="pubmed">25221475</ArticleId><ArticleId IdType="pmc">4148895</ArticleId></ArticleIdList></Reference><Reference><Citation>Asuthkar S, Demirkhanyan L, Sun X, Elustondo PA, Krishnan V, Baskaran P, Velpula KK, Thyagarajan B, Pavlov EV, Zakharian E (2015) The TRPM8 protein is a testosterone receptor: II. Functional evidence for an ionotropic effect of testosterone on TRPM8. J Biol Chem 290:2670&#x2013;2688</Citation><ArticleIdList><ArticleId IdType="pubmed">25480785</ArticleId></ArticleIdList></Reference><Reference><Citation>Bennetts B, Parker MW (2013) Molecular determinants of common gating of a ClC chloride channel. Nat Commun 4:2507</Citation><ArticleIdList><ArticleId IdType="pubmed">24064982</ArticleId></ArticleIdList></Reference><Reference><Citation>Bi MM, Hong S, Zhou HY, Wang HW, Wang LN, Zheng YJ (2014) Chloride channelopathies of ClC-2. Int J Mol Sci 15:218&#x2013;249</Citation></Reference><Reference><Citation>B&#xf6;sl MR, Stein V, H&#xfc;bner C, Zdebik AA, Jordt SE, Mukhopadhyay AK, Davidoff MS, Holstein AF, Jentsch TJ (2001) Male germ cells and photoreceptors, both dependent on close cell&#x2013;cell interactions, degenerate upon ClC-2 Cl<sup>&#x2212;</sup> channel disruption. EMBO J 20:1289&#x2013;1299</Citation><ArticleIdList><ArticleId IdType="pubmed">11250895</ArticleId><ArticleId IdType="pmc">145530</ArticleId></ArticleIdList></Reference><Reference><Citation>Bushart DD, Chopra R, Singh V, Murphy GG, Wulff H, Shakkottai VG (2018) Targeting potassium channels to treat cerebellar ataxia. Ann Clin Transl Neurol 5:297&#x2013;314</Citation><ArticleIdList><ArticleId IdType="pubmed">29560375</ArticleId><ArticleId IdType="pmc">5846455</ArticleId></ArticleIdList></Reference><Reference><Citation>Chopra R, Shakkottai VG (2014) The role for alterations in neuronal activity in the pathogenesis of polyglutamine repeat disorders. Neurotherapeutics 11:751&#x2013;763</Citation><ArticleIdList><ArticleId IdType="pubmed">24986674</ArticleId><ArticleId IdType="pmc">4391381</ArticleId></ArticleIdList></Reference><Reference><Citation>Chopra R, Bushart DD, Shakkottai VG (2018) Dendritic potassium channel dysfunction may contribute to dendrite degeneration in spinocerebellar ataxia type 1. PLoS One 13:e0198040</Citation><ArticleIdList><ArticleId IdType="pubmed">29847609</ArticleId><ArticleId IdType="pmc">5976172</ArticleId></ArticleIdList></Reference><Reference><Citation>Clark S, Jordt SE, Jentsch TJ, Mathie A (1998) Characterization of the hyperpolarization-activated chloride current in dissociated rat sympathetic neurons. J Physiol 506:665&#x2013;678</Citation><ArticleIdList><ArticleId IdType="pubmed">9503329</ArticleId><ArticleId IdType="pmc">2230754</ArticleId></ArticleIdList></Reference><Reference><Citation>Cortes CJ, La Spada AR (2014) Motor neuron degeneration in spinal and bulbar muscular atrophy is a skeletal muscle-driven process: relevance to therapy development and implications for related motor neuron diseases. Rare Dis 2:e962402</Citation><ArticleIdList><ArticleId IdType="pubmed">26942099</ArticleId><ArticleId IdType="pmc">4755247</ArticleId></ArticleIdList></Reference><Reference><Citation>Cortez MA, Li C, Whitehead SN, Dhani U, D&#x2019;antonio C, Huan LJ, Bennett AL et al (2010) Disruption of ClC-2 expression is associated with progressive neurodegeneration in aging mice. Neuroscience 167:154&#x2013;162</Citation><ArticleIdList><ArticleId IdType="pubmed">20116415</ArticleId></ArticleIdList></Reference><Reference><Citation>De Koninck Y (2007) Altered chloride homeostasis in neurological disorders: a new target. Curr Opin Pharmacol 7:93&#x2013;99</Citation><ArticleIdList><ArticleId IdType="pubmed">17182282</ArticleId></ArticleIdList></Reference><Reference><Citation>Dell'Orco JM, Pulst SM, Shakkottai VG (2017) Potassium channel dysfunction underlies Purkinje neuron spiking abnormalities in spinocerebellar ataxia type 2. Hum Mol Genet 26:3935&#x2013;3945</Citation><ArticleIdList><ArticleId IdType="pubmed">29016852</ArticleId><ArticleId IdType="pmc">5886219</ArticleId></ArticleIdList></Reference><Reference><Citation>Enz R, Ross BJ, Cutting GR (1999) Expression of the voltage-gated chloride channel ClC-2 in rod bipolar cells of the rat retina. J Neurosci 19:9841&#x2013;9847</Citation><ArticleIdList><ArticleId IdType="pubmed">10559393</ArticleId><ArticleId IdType="pmc">6782979</ArticleId></ArticleIdList></Reference><Reference><Citation>Fahlke C (2001) Ion permeation and selectivity in ClC-type chloride channels. Am J Physiol Ren Physiol 280:F748&#x2013;F757</Citation></Reference><Reference><Citation>Fernandes-Rosa FL, Daniil G, Orozco IJ, G&#xf6;ppner C, El Zein R, Jain V et al (2018) A gain-of-function mutation in the CLCN2 chloride channel gene causes primary aldosteronism. Nat Genet 50:355&#x2013;361</Citation><ArticleIdList><ArticleId IdType="pubmed">29403012</ArticleId></ArticleIdList></Reference><Reference><Citation>Furukawa T, Kurokawa J (2008) Non-genomic regulation of cardiac ion channels by sex hormones. Cardiovasc Hematol Dis Drug Targets 8(4):245&#x2013;251</Citation></Reference><Reference><Citation>Gray PC, Scott JD, Catterall WA (1998) Regulation of ion channels by cAMP-dependent protein kinase and A-kinase anchoring proteins. Curr Opin Neurobiol 8:330&#x2013;334</Citation><ArticleIdList><ArticleId IdType="pubmed">9687361</ArticleId></ArticleIdList></Reference><Reference><Citation>Guo Z, Lu T, Peng L, Cheng H, Peng F, Li J, Lu Z, Chen S, Qiu W (2019) CLCN2-related leukoencephalopathy: a case report and review of the literature. BMC Neurol 19:156</Citation><ArticleIdList><ArticleId IdType="pubmed">31291907</ArticleId><ArticleId IdType="pmc">6617604</ArticleId></ArticleIdList></Reference><Reference><Citation>Hou X, Zhang R, Wang J, Li Y, Li F, Zhang Y, Zheng X, Shen Y, Wang Y, Zhou L (2018) CLC-2 is a positive modulator of oligodendrocyte precursor cell differentiation and myelination. Mol Med Rep 17:4515&#x2013;4523</Citation><ArticleIdList><ArticleId IdType="pubmed">29344669</ArticleId><ArticleId IdType="pmc">5802228</ArticleId></ArticleIdList></Reference><Reference><Citation>Hsu YT, Chang YG, Chern Y (2018) Insights into GABA<sub>A</sub>ergic system alteration in Huntington&#x2019;s disease. Open Biol 8:180165</Citation><ArticleIdList><ArticleId IdType="pubmed">30518638</ArticleId><ArticleId IdType="pmc">6303784</ArticleId></ArticleIdList></Reference><Reference><Citation>Huberfeld G, Wittner L, Clemenceau S, Baulac M, Kaila K, Miles R, Rivera C (2007) Perturbed chloride homeostasis and GABAergic signaling in human temporal lobe epilepsy. J Neurosci 27:9866&#x2013;9873</Citation><ArticleIdList><ArticleId IdType="pubmed">17855601</ArticleId><ArticleId IdType="pmc">6672644</ArticleId></ArticleIdList></Reference><Reference><Citation>Jayakar SS, Pugh PC, Dale Z, Starr ER, Cole S, Margiotta JF (2014) PACAP induces plasticity at autonomic synapses by nAChR-dependent NOS1 activation and AKAP-mediated PKA targeting. Mol Cell Neurosci 63:1&#x2013;12</Citation><ArticleIdList><ArticleId IdType="pubmed">25168001</ArticleId></ArticleIdList></Reference><Reference><Citation>Jentsch TJ, Pusch M (2018) CLC chloride channels and transporters: structure, function, physiology, and disease. Physiol Rev 98:1493&#x2013;1590</Citation><ArticleIdList><ArticleId IdType="pubmed">29845874</ArticleId></ArticleIdList></Reference><Reference><Citation>Jentsch TJ, Stein V, Weinreich F, Zdebik AA (2002) Molecular structure and physiological function of chloride channels. Physiol Rev 82:503&#x2013;568</Citation><ArticleIdList><ArticleId IdType="pubmed">11917096</ArticleId></ArticleIdList></Reference><Reference><Citation>Jeub M, Herbst M, Spauschus A, Fleischer H, Klockgether T, Wuellner U, Evert BO (2006) Potassium channel dysfunction and depolarized resting membrane potential in a cell model of SCA3. Exp Neurol 201:182&#x2013;192</Citation><ArticleIdList><ArticleId IdType="pubmed">16765348</ArticleId></ArticleIdList></Reference><Reference><Citation>Jeworutzki E, L&#xf3;pez-Hern&#xe1;ndez T, Capdevila-Nortes X, Sirisi S, Bengtsson L, Montolio M, Zifarelli G, Arnedo T, M&#xfc;ller CS, Schulte U, Nunes V, Mart&#xed;nez A, Jentsch TJ, Gasull X, Pusch M, Est&#xe9;vez R (2012) GlialCAM, a protein defective in a leukodystrophy, serves as a ClC-2 Cl<sup>&#x2212;</sup> channel auxiliary subunit. Neuron 73:951&#x2013;961</Citation><ArticleIdList><ArticleId IdType="pubmed">22405205</ArticleId><ArticleId IdType="pmc">3334819</ArticleId></ArticleIdList></Reference><Reference><Citation>Jimenez-Gardu&#xf1;o AM, Juarez-Hernandez LJ, Polanco MJ, Tosatto L, Michelatti D, Arosio D et al (2017) Altered ionic currents and amelioration by IGF-1 and PACAP in motoneuron-derived cells modelling SBMA. Biophys Chem 229:68&#x2013;76</Citation><ArticleIdList><ArticleId IdType="pubmed">28511915</ArticleId></ArticleIdList></Reference><Reference><Citation>Kajita H, Omori K, Matsuda H (2000) The chloride channel ClC-2 contributes to the inwardly rectifying Cl<sup>&#x2212;</sup> conductance in cultured porcine choroid plexus epithelial cells. J Physiol 523:313&#x2013;324</Citation><ArticleIdList><ArticleId IdType="pubmed">10699077</ArticleId><ArticleId IdType="pmc">2269808</ArticleId></ArticleIdList></Reference><Reference><Citation>Kennedy WR, Alter M, Sung JH (1968) Progressive proximal spinal and bulbar muscular atrophy of late onset. A sex-linked recessive trait. Neurology 18:671&#x2013;680</Citation><ArticleIdList><ArticleId IdType="pubmed">4233749</ArticleId></ArticleIdList></Reference><Reference><Citation>Korkmaz O, Ay H, Ulupinar E, Tun&#xe7;el N (2012) Vasoactive intestinal peptide enhances striatal plasticity and prevents dopaminergic cell loss in Parkinsonian rats. J Mol Neurosci 48:565&#x2013;573</Citation><ArticleIdList><ArticleId IdType="pubmed">22544516</ArticleId></ArticleIdList></Reference><Reference><Citation>Kumar P, Kumar D, Jha SK, Jha NK, Ambasta RK (2016) Ion channels in neurological disorders. Adv Protein Chem Struct Biol 103:97&#x2013;136</Citation><ArticleIdList><ArticleId IdType="pubmed">26920688</ArticleId></ArticleIdList></Reference><Reference><Citation>La Spada AR, Wilson EM, Lubahn DB, Harding AE, Fischbeck KH (1991) Androgen receptor gene mutations in X-linked spinal and bulbar muscular atrophy. Nature 352:77&#x2013;79</Citation><ArticleIdList><ArticleId IdType="pubmed">2062380</ArticleId></ArticleIdList></Reference><Reference><Citation>Lieberman AP, Shakkottai VG, Albin RL (2019) Polyglutamine repeats in neurodegenerative diseases. Annu Rev Pathol 14:1&#x2013;27</Citation><ArticleIdList><ArticleId IdType="pubmed">30089230</ArticleId></ArticleIdList></Reference><Reference><Citation>Mahadevan V, Woodin MA (2016) Regulation of neuronal chloride homeostasis by neuromodulators. J Physiol 594:2593&#x2013;2605</Citation><ArticleIdList><ArticleId IdType="pubmed">26876607</ArticleId><ArticleId IdType="pmc">4865579</ArticleId></ArticleIdList></Reference><Reference><Citation>Matsuyama Z, Wakamori M, Mori Y, Kawakami H, Nakamura S, Imoto K (1999) Direct alteration of the P/Q-type Ca<sup>2+</sup> channel property by polyglutamine expansion in spinocerebellar ataxia 6. J Neurosci 19:RC14</Citation><ArticleIdList><ArticleId IdType="pubmed">10366652</ArticleId><ArticleId IdType="pmc">6782654</ArticleId></ArticleIdList></Reference><Reference><Citation>Milioto C, Malena A, Maino E, Polanco MJ, Marchioretti C, Borgia D, Pereira MG, Blaauw B, Lieberman AP, Venturini R, Plebani M, Sambataro F, Vergani L, Pegoraro E, Sorar&#xf9; G, Pennuto M (2017) Beta-agonist stimulation ameliorates the phenotype of spinal and bulbar muscular atrophy mice and patient-derived myotubes. Sci Rep 7:41046</Citation><ArticleIdList><ArticleId IdType="pubmed">28117338</ArticleId><ArticleId IdType="pmc">5259768</ArticleId></ArticleIdList></Reference><Reference><Citation>Narayanan G, Sheila M, Chai J, Stanton LW (2017) Generation of sibling-matched induced pluripotent stem cell lines from spinal and bulbar muscular atrophy patients. Stem Cell Res 20:30&#x2013;33</Citation><ArticleIdList><ArticleId IdType="pubmed">28395737</ArticleId></ArticleIdList></Reference><Reference><Citation>Niemeyer MI, Cid LP, Sepulveda FV, Blanz J, Auberson M, Jentsch TJ (2010) No evidence for a role of CLCN2 variants in idiopathic generalized epilepsy. Nat Genet 42:3</Citation><ArticleIdList><ArticleId IdType="pubmed">20037607</ArticleId></ArticleIdList></Reference><Reference><Citation>Nighot PK, Blikslager AT (2012) Chloride channel ClC-2 modulates tight junction barrier function via intracellular trafficking of occludin. Am J Phys Cell Physiol 302:C178&#x2013;C187</Citation></Reference><Reference><Citation>Oki K, Halievski K, Vicente L, Xu Y, Zeolla D, Poort J, Katsuno M, Adachi H, Sobue G, Wiseman RW, Breedlove SM, Jordan CL (2015) Contractile dysfunction in muscle may underlie androgen-dependent motor dysfunction in spinal bulbar muscular atrophy. J Appl Physiol 118:941&#x2013;952</Citation><ArticleIdList><ArticleId IdType="pubmed">25663674</ArticleId><ArticleId IdType="pmc">4385878</ArticleId></ArticleIdList></Reference><Reference><Citation>Onodera K, Shimojo D, Ishihara Y, Yano M, Miya F, Banno H, Kuzumaki N, Ito T, Okada R, de Ara&#xfa;jo Herculano B, Ohyama M, Yoshida M, Tsunoda T, Katsuno M, Doyu M, Sobue G, Okano H, Okada Y (2020) Unveiling synapse pathology in spinal bulbar muscular atrophy by genome-wide transcriptome analysis of purified motor neurons derived from disease specific iPSCs. Mol Brain 13:18</Citation><ArticleIdList><ArticleId IdType="pubmed">32070397</ArticleId><ArticleId IdType="pmc">7029484</ArticleId></ArticleIdList></Reference><Reference><Citation>Palazzolo I, Burnett BG, Young JE, Brenne PL, La Spada AR, Fischbeck KH et al (2007) Akt blocks ligand binding and protects against expanded polyglutamine androgen receptor toxicity. Hum Mol Genet 16:1593&#x2013;1603</Citation><ArticleIdList><ArticleId IdType="pubmed">17470458</ArticleId></ArticleIdList></Reference><Reference><Citation>Palazzolo I, Stack C, Kong L, Musaro A, Adachi H, Katsuno M, Sobue G, Taylor JP, Sumner CJ, Fischbeck KH, Pennuto M (2009) Overexpression of IGF-1 in muscle attenuates disease in a mouse model of spinal and bulbar muscular atrophy. Neuron 63:316&#x2013;328</Citation><ArticleIdList><ArticleId IdType="pubmed">19679072</ArticleId><ArticleId IdType="pmc">2735765</ArticleId></ArticleIdList></Reference><Reference><Citation>Parodi S, Pennuto M (2011) Neurotoxic effects of androgens in spinal and bulbar muscular atrophy. Front Neuroendocrinol 32:416&#x2013;425</Citation><ArticleIdList><ArticleId IdType="pubmed">21745497</ArticleId></ArticleIdList></Reference><Reference><Citation>Pennuto M, Basso M (2016) In vitro and in vivo modeling of spinal and bulbar muscular atrophy. J Mol Neurosci 58:365&#x2013;373</Citation><ArticleIdList><ArticleId IdType="pubmed">26614347</ArticleId></ArticleIdList></Reference><Reference><Citation>Pilzer I, Gozes I (2006) VIP provides cellular protection through a specific splice variant of the PACAP receptor: a new neuroprotection target. Peptides 27:2867&#x2013;2876</Citation><ArticleIdList><ArticleId IdType="pubmed">16905223</ArticleId></ArticleIdList></Reference><Reference><Citation>Polanco MJ, Pennuto M (2018) Pituitary adenylyl Cyclase activating polypeptide (PACAP) signaling and the cell cycle machinery in neurodegenerative diseases. Curr Pharm Des 24:3878&#x2013;3891</Citation><ArticleIdList><ArticleId IdType="pubmed">30479210</ArticleId></ArticleIdList></Reference><Reference><Citation>Polanco MJ, Parodi S, Piol D, Stack C, Chivet M, Contestabile A et al (2016) Adenylyl cyclase activating polypeptide reduces phosphorylation and toxicity of the polyglutamine-expanded androgen receptor in spinobulbar muscular atrophy. Sci Transl Med 8:370ra181</Citation><ArticleIdList><ArticleId IdType="pubmed">28003546</ArticleId></ArticleIdList></Reference><Reference><Citation>Poroca DR, Pelis RM, Chappe VM (2017) ClC channels and transporters: structure, physiological functions, and implications in human chloride channelopathies. Front Pharmacol 8:151</Citation><ArticleIdList><ArticleId IdType="pubmed">28386229</ArticleId><ArticleId IdType="pmc">5362633</ArticleId></ArticleIdList></Reference><Reference><Citation>Price TJ, Cervero F, Gold MS, Hammond DL, Prescott SA (2009) Chloride regulation in the pain pathway. Brain Res Rev 60:149&#x2013;170</Citation><ArticleIdList><ArticleId IdType="pubmed">19167425</ArticleId></ArticleIdList></Reference><Reference><Citation>Querin G, Bede P, Marchand-Pauvert V, Pradat PF (2018) Biomarkers of spinal and bulbar muscle atrophy (SBMA): a comprehensive review. Front Neurol 9:844</Citation><ArticleIdList><ArticleId IdType="pubmed">30364135</ArticleId><ArticleId IdType="pmc">6191472</ArticleId></ArticleIdList></Reference><Reference><Citation>Ranganathan S, Harmison GG, Meyertholen K, Pennuto M, Burnett BG, Fischbeck KH (2009) Mitochondrial abnormalities in spinal and bulbar muscular atrophy. Hum Mol Genet 18:27&#x2013;42</Citation><ArticleIdList><ArticleId IdType="pubmed">18824496</ArticleId></ArticleIdList></Reference><Reference><Citation>Ratt&#xe9; S, Prescott SA (2011) ClC-2 channels regulate neuronal excitability, not intracellular chloride levels. J Neurosci 31:15838&#x2013;15843</Citation><ArticleIdList><ArticleId IdType="pubmed">22049427</ArticleId><ArticleId IdType="pmc">6623024</ArticleId></ArticleIdList></Reference><Reference><Citation>Reglodi D, Kiss P, Lubics A, Tamas A (2011) Review on the protective effects of PACAP in models of neurodegenerative diseases in vitro and in vivo. Curr Pharm Des 17:962&#x2013;972</Citation><ArticleIdList><ArticleId IdType="pubmed">21524257</ArticleId></ArticleIdList></Reference><Reference><Citation>Rinaldi C, Malik B, Greensmith L (2016) Targeted molecular therapies for SBMA. J Mol Neurosci 58:335&#x2013;342</Citation><ArticleIdList><ArticleId IdType="pubmed">26576772</ArticleId></ArticleIdList></Reference><Reference><Citation>Rinke I, Artmann J, Stein V (2010) ClC-2 voltage-gated channels constitute part of the background conductance and assist chloride extrusion. J Neurosci 30:4776&#x2013;4786</Citation><ArticleIdList><ArticleId IdType="pubmed">20357128</ArticleId><ArticleId IdType="pmc">6632307</ArticleId></ArticleIdList></Reference><Reference><Citation>Roncador A, Jimenez-Gardu&#xf1;o AM, Pasquardini L, Giusti G, Cornella N, Lunelli L, Potrich C, Bartali R, Aversa L, Verucchi R, Serra MD, Caponi S, Iannotta S, Macchi P, Musio C (2017) Primary cortical neurons on PMCS TiO<sub>2</sub> films towards bio-hybrid memristive device: a morpho-functional study. Biophys Chem 229:115&#x2013;122</Citation><ArticleIdList><ArticleId IdType="pubmed">28476206</ArticleId></ArticleIdList></Reference><Reference><Citation>Salazar-Grueso EF, Kim S, Kim H (1991) Embryonic mouse spinal cord motor neuron hybrid cells. Neuroreport 2:505&#x2013;508</Citation><ArticleIdList><ArticleId IdType="pubmed">1751804</ArticleId></ArticleIdList></Reference><Reference><Citation>Scaramuzzino C, Casci I, Parodi S, Lievens PMJ, Polanco MJ, Milioto C, Chivet M, Monaghan J, Mishra A, Badders N, Aggarwal T, Grunseich C, Sambataro F, Basso M, Fackelmayer FO, Taylor JP, Pandey UB, Pennuto M (2015) Protein arginine methyltransferase 6 enhances polyglutamine-expanded androgen receptor function and toxicity in spinal and bulbar muscular atrophy. Neuron 85:88&#x2013;100</Citation><ArticleIdList><ArticleId IdType="pubmed">25569348</ArticleId><ArticleId IdType="pmc">4305189</ArticleId></ArticleIdList></Reference><Reference><Citation>Sculptoreanu A, Abramovici H, Abdullah AA, Bibikova A, Panet-Raymond V, Frankel D et al (2000) Increased T-type Ca<sup>2+</sup> channel activity as a determinant of cellular toxicity in neuronal cell lines expressing polyglutamine-expanded human androgen receptors. Mol Cell Biochem 203:23&#x2013;31</Citation><ArticleIdList><ArticleId IdType="pubmed">10724329</ArticleId></ArticleIdList></Reference><Reference><Citation>Smith RL, Clayton GH, Wilcox CL, Escudero KW, Staley KJ (1995) Differential expression of an inwardly rectifying chloride conductance in rat brain neurons: a potential mechanism for cell-specific modulation of postsynaptic inhibition. J Neurosci 15:4057&#x2013;4067</Citation><ArticleIdList><ArticleId IdType="pubmed">7751965</ArticleId><ArticleId IdType="pmc">6578181</ArticleId></ArticleIdList></Reference><Reference><Citation>Starr ER, Margiotta JF (2017) Pituitary adenylate cyclase activating polypeptide induces long-term, transcription-dependent plasticity and remodeling at autonomic synapses. Mol Cell Neurosci 85:170&#x2013;182</Citation><ArticleIdList><ArticleId IdType="pubmed">29017814</ArticleId></ArticleIdList></Reference><Reference><Citation>St&#xf6;lting G, Teodorescu G, Begemann B, Schubert J, Nabbout R, Toliat MR, Sander T, N&#xfc;rnberg P, Lerche H, Fahlke C (2013) Regulation of ClC-2 gating by intracellular ATP. Pflugers Arch - Eur J Physiol 465:1423&#x2013;1437</Citation></Reference><Reference><Citation>St&#xf6;lting G, Fischer M, Fahlke C (2014) CLC channel function and dysfunction in health and disease. Front Physiol 5:378</Citation><ArticleIdList><ArticleId IdType="pubmed">25339907</ArticleId><ArticleId IdType="pmc">4188032</ArticleId></ArticleIdList></Reference><Reference><Citation>Sulis Sato S, Artoni P, Landi S, Cozzolino O, Parra R, Pracucci E, Trovato F, Szczurkowska J, Luin S, Arosio D, Beltram F, Cancedda L, Kaila K, Ratto GM (2017) Simultaneous two-photon imaging of intracellular chloride concentration and pH in mouse pyramidal neurons in vivo. Proc Natl Acad Sci U S A 114:E8770&#x2013;E8779</Citation><ArticleIdList><ArticleId IdType="pubmed">28973889</ArticleId><ArticleId IdType="pmc">5642681</ArticleId></ArticleIdList></Reference><Reference><Citation>Thiemann A, Gr&#xfc;nder S, Pusch M, Jentsch TJ (1992) A chloride channel widely expressed in epithelial and non-epithelial cells. Nature 356:57&#x2013;60</Citation><ArticleIdList><ArticleId IdType="pubmed">1311421</ArticleId></ArticleIdList></Reference><Reference><Citation>Thompson CH, Olivetti PR, Fuller MD, Freeman CS, McMaster D, French RJ, Pohl J, Kubanek J, McCarty NA (2009) Isolation and characterization of a high affinity peptide inhibitor of ClC-2 chloride channels. J Biol Chem 284:26051&#x2013;22662</Citation><ArticleIdList><ArticleId IdType="pubmed">19574231</ArticleId><ArticleId IdType="pmc">2758005</ArticleId></ArticleIdList></Reference><Reference><Citation>Tomimatsu N, Arakawa Y (2008) Survival-promoting activity of pituitary adenylate cyclase-activating polypeptide in the presence of phosphodiesterase inhibitors on rat motoneurons in culture: cAMP&#x2013;protein kinase A-mediated survival. J Neurochem 107:628&#x2013;635</Citation><ArticleIdList><ArticleId IdType="pubmed">18717811</ArticleId></ArticleIdList></Reference><Reference><Citation>Tripathy D, Migazzi A, Costa F, Roncador A, Gatto P, Fusco F, Boeri L, Albani D, Ju&#xe1;rez-Hern&#xe1;ndez JL, Musio C, Colombo L, Salmona M, Wilhelmus MMM, Drukarch B, Pennuto M, Basso M (2020) Increased transcription of transglutaminase 1 mediates neuronal death in in vitro models of neuronal stress and A&#x3b2;1-42-mediated toxicity. Neurobiol Dis 140:104849. https://doi.org/10.1016/j.nbd.2020.104849</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nbd.2020.104849</ArticleId><ArticleId IdType="pubmed">32222473</ArticleId></ArticleIdList></Reference><Reference><Citation>Tsuchikawa D, Nakamachi T, Tsuchida M, Wada Y, Hori M, Farkas J, Yoshikawa A, Kagami N, Imai N, Shintani N, Hashimoto H, Atsumi T, Shioda S (2012) Neuroprotective effect of endogenous pituitary adenylate cyclase-activating polypeptide on spinal cord injury. J Mol Neurosci 48:508&#x2013;517</Citation><ArticleIdList><ArticleId IdType="pubmed">22674051</ArticleId></ArticleIdList></Reference><Reference><Citation>Yu Z, Dadgar N, Albertelli M, Gruis K, Jordan C, Robins DM, Lieberman AP (2006) Androgen-dependent pathology demonstrates myopathic contribution to the Kennedy disease phenotype in a mouse knock-in model. J Clin Invest 116:2663&#x2013;2672</Citation><ArticleIdList><ArticleId IdType="pubmed">16981011</ArticleId><ArticleId IdType="pmc">1564432</ArticleId></ArticleIdList></Reference><Reference><Citation>Zawilska JB, Dejda A, Niewiadomski P, Gozes I, Nowak JZ (2005) Receptors for VIP and PACAP in guinea pig cerebral cortex: effects on cyclic AMP synthesis and characterization by 125I-VIP binding. J Mol Neurosci 25:215&#x2013;224</Citation><ArticleIdList><ArticleId IdType="pubmed">15800375</ArticleId></ArticleIdList></Reference><Reference><Citation>Z&#xfa;&#xf1;iga L, Niemeyer MI, Varela D, Catal&#xe1;n M, Cid LP, Sep&#xfa;lveda FV (2004) The voltage-dependent ClC-2 chloride channel has a dual gating mechanism. J Physiol 555:671&#x2013;682</Citation><ArticleIdList><ArticleId IdType="pubmed">14724195</ArticleId><ArticleId IdType="pmc">1664870</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>